Guardant Health
GH
#1156
Rank
A$29.30 B
Marketcap
A$216.62
Share price
1.30%
Change (1 day)
47.54%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: A$29.30 Billion

As of November 2026 Guardant Health has a market cap of A$29.30 Billion. This makes Guardant Health the world's 1156th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$29.30 B46.77%
2025A$19.96 B230.23%
2024A$6.04 B25.47%
2023A$4.81 B17.7%
2022A$4.09 B-70.81%
2021A$14.02 B-16.3%
2020A$16.75 B59.88%
2019A$10.48 B129.04%
2018A$4.57 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Guardant Health was reported to be:

A$29.30 Billion
by Nasdaq info icon info icon
A$29.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
A$3.61 B-87.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$62.65 B 113.79%๐Ÿ‡บ๐Ÿ‡ธ USA